According to Bionomics's latest financial reports the company's current EPS (TTM) is -$5.12. In 2022 the company made an earnings per share (EPS) of -$5.12 a decrease over its 2021 EPS that were of -$2.15.
Year | EPS | Change |
---|---|---|
2022 | -$5.12 | 137.66% |
2021 | -$2.15 | 7.34% |
2020 | -$2.01 | -30.72% |
2019 | -$2.90 | -64.88% |
2018 | -$8.24 | 243.83% |
2017 | -$2.40 | -60.32% |
2016 | -$6.04 | -11.65% |
2015 | -$6.84 | -507.39% |
2014 | $1.68 | -130.56% |
2013 | -$5.49 | 169.05% |
2012 | -$2.04 | -70.28% |
2011 | -$6.87 | 36.51% |
2010 | -$5.03 | 0.63% |
2009 | -$5.00 | 12.2% |
2008 | -$4.46 | -34.98% |
2007 | -$6.86 | 22.52% |
2006 | -$5.60 | -46.29% |
2005 | -$10.42 | -2.7% |
2004 | -$10.71 | -34.51% |
2003 | -$16.35 | 18.95% |
2002 | -$13.74 | -13.64% |
2001 | -$15.92 | 10% |
2000 | -$14.47 | -9.09% |
1999 | -$15.92 |